No Data
No Data
ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns With EPS Projections Amidst Regulatory ...
ARS Pharmaceuticals First Quarter 2024 Earnings: US$0.11 Loss per Share (Vs US$0.16 Loss in 1Q 2023)
ARS Pharmaceuticals Unveils Updated Corporate Presentation
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$934.37K in Common Stock
$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on May 7, 2024 at an average price of $9.3437 for a total value of $934.37K. This transaction involv
Express News | ARS Pharmaceuticals Inc: Qtrly Net Loss per Share, Basic and Diluted $0.11
Express News | ARS Pharmaceuticals Inc: $223.6 Mln in Cash and Securities as of March 31, Providing an Expected Operating Runway of at Least Three Years